Diaceutics (LON:DXRX) Hits New 1-Year High – Here’s What Happened

Diaceutics PLC (LON:DXRX)’s share price hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as GBX 151 ($1.88) and last traded at GBX 145.50 ($1.82), with a volume of 416157 shares. The stock had previously closed at GBX 137.50 ($1.72).

Analyst Ratings Changes

A number of equities analysts have recently weighed in on DXRX shares. Canaccord Genuity Group reiterated a “buy” rating and issued a GBX 160 ($2.00) target price on shares of Diaceutics in a report on Tuesday, December 17th. Canaccord Genuity Group reissued a “buy” rating and set a GBX 160 ($2.00) price objective on shares of Diaceutics in a research report on Tuesday, December 17th.

Diaceutics Stock Performance

The company has a debt-to-equity ratio of 2.93, a quick ratio of 9.92 and a current ratio of 4.85. The firm has a 50 day moving average of GBX 121.38 and a two-hundred day moving average of GBX 126.26. The stock has a market cap of £122.90 million, a P/E ratio of -4,850.00 and a beta of 0.58.

About Diaceutics

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.